Your browser doesn't support javascript.
loading
Corrigendum: SNORA72 activates the Notch1/c-Myc pathway to promote stemness transformation of ovarian cancer cells.
Zhang, Liwen; Ma, Rong; Gao, Mengcong; Zhao, Yanyun; Lv, Xuemei; Zhu, Wenjing; Han, Li; Su, Panpan; Fan, Yue; Yan, Yuanyuan; Zhao, Lin; Ma, Heyao; Wei, Minjie; He, Miao.
Afiliação
  • Zhang L; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Ma R; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, China.
  • Gao M; Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, China Medical University, Shenyang, China.
  • Zhao Y; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Shenyang, China.
  • Lv X; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Zhu W; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, China.
  • Han L; Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, China Medical University, Shenyang, China.
  • Su P; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Shenyang, China.
  • Fan Y; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Yan Y; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, China.
  • Zhao L; Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, China Medical University, Shenyang, China.
  • Ma H; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Shenyang, China.
  • Wei M; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • He M; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, China.
Front Cell Dev Biol ; 10: 819798, 2022.
Article em En | MEDLINE | ID: mdl-36092736
[This corrects the article DOI: 10.3389/fcell.2020.583087.].
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article